General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.19.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Convertible Series F Preferred Stock
Convertible Series D Preferred Stock
Convertible Series C Preferred Stock
Redeemable Convertible Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Warrants
Accumulated Deficit
Total
Balance at Dec. 31, 2016     $ 293,669 $ 1,169,663          
Balance (Shares) at Dec. 31, 2016     386 4,031          
Balance at Dec. 31, 2016         $ 21,563 $ 7,163,064 $ 837,711 $ (10,936,573) $ (2,914,235)
Balance (in shares) at Dec. 31, 2016         21,563,163        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued for services         $ 605 186,945     187,550
Common stock issued for services (in shares)         605,000        
Common stock warrants issued for services             145,200   145,200
Stock based compensation expense           608,676     608,676
Issuance of Series D Preferred Stock net of issuance costs of $183,343   $ 1,016,657              
Issuance of Series D Preferred Stock net of issuance costs of $183,343 (in shares)   1,200              
Issuance of Series F Preferred Stock net of issuance costs of $118,855 and $103,364 put option liability $ 1,777,781                
Issuance of Series F Preferred Stock net of issuance costs of $118,855 and $103,364 put option liability (in shares) 2,000                
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.25 and $0.15 per share for December 31, 2017 and $0.10 and $0.001 per share for December 31, 2018       $ (347,462) $ 5,911 350,810     356,721
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.80 and $0.40 per share for December 31, 2016 and $0.25 and $0.15 per share for December 31, 2017 (in shares)       (1,197.45) 5,910,666        
Conversion of Series C Preferred Stock to common stock at $0.25 per share for December 31, 2017     $ (293,669)   $ 1,544 292,125     293,669
Conversion of Series C Preferred Stock to common stock at $0.40 and $0.25 per share for December 31, 2016 and 2017 respectively (in shares)     (386)   1,544,000        
Conversion of Series D Preferred Stock to common stock at $0.25 and $0.10 per share for December 31, 2016 and December 31, 2017, respectively.   $ (847,210)     $ 4,000 843,211     847,211
Conversion of Series D Preferred Stock to common stock at $0.25 per share (in shares)   (1,000)     4,000,000        
Beneficial conversion feature upon issuance of Series C Preferred Stock           175,000     175,000
Deemed dividend from beneficial conversion feature of Series C Preferred Stock           (175,000)     (175,000)
Beneficial conversion feature upon issuance of Series D Preferred Stock           536,000     536,000
Deemed dividend from beneficial conversion feature of Series D Preferred Stock           (536,000)     (536,000)
Beneficial conversion feature upon issuance of Series F Preferred Stock           333,000     333,000
Deemed dividend from beneficial conversion feature of Series F Preferred Stock           (333,000)     (333,000)
Net loss for the year               (3,094,298) (3,094,298)
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447   $ 822,201 $ 33,623 9,444,831 982,911 (14,030,871) (3,569,506)
Balance (in shares) at Dec. 31, 2017 2,000 200   2,833.55 33,622,829        
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447   $ 822,201          
Balance (Shares) at Dec. 31, 2017 2,000 200   2,833.55          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock based compensation expense         $ 2,500 227,109     229,609
Stock based compensation expense (in shares)         2,500,000        
Issuance of common stock net of issuance costs of $16,900         $ 32,500 (32,500)      
Issuance of common stock net of issuance costs of $16,900 (in shares)         32,500,000        
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.25 and $0.15 per share for December 31, 2017 and $0.10 and $0.001 per share for December 31, 2018       $ (822,201) $ 28,385 800,530     828,915
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.80 and $0.40 per share for December 31, 2016 and $0.25 and $0.15 per share for December 31, 2017 (in shares)       (2,834) 28,385,000        
Conversion of Series D Preferred Stock to common stock at $0.25 and $0.10 per share for December 31, 2016 and December 31, 2017, respectively.   $ (169,447)     $ 2,000 167,447     169,447
Conversion of Series D Preferred Stock to common stock at $0.25 per share (in shares)   (200)     2,000,000        
Conversion of Series F Preferred Stock to common stock at $0.10 per share $ (1,777,781)       $ 20,000 1,757,781     1,777,781
Conversion of Series F Preferred Stock to common stock at $0.10 per share (in shares) (2,000)       20,000,000        
Conversion of secured convertible promissory note - related party and accrued interest (in shares)         9,000,000        
Conversion of secured convertible promissory note - related party and accrued interest         $ 9,000 1,691,878     1,700,878
Series B warrant exercises         $ 4,406 1,318,284     1,322,690
Series B warrant exercises (in shares)         4,406,250        
Net loss for the year               (8,213,793) (8,213,793)
Balance at Mar. 31, 2018         $ 132,414 16,358,271   (22,244,664) (5,753,979)
Balance (in shares) at Mar. 31, 2018         132,414,079        
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447   $ 822,201          
Balance (Shares) at Dec. 31, 2017 2,000 200   2,833.55          
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447   $ 822,201 $ 33,623 9,444,831 982,911 (14,030,871) (3,569,506)
Balance (in shares) at Dec. 31, 2017 2,000 200   2,833.55 33,622,829        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss for the year                 (10,875,793)
Balance at Jun. 30, 2018         $ 132,702 16,528,683   (24,906,664) (8,245,279)
Balance (in shares) at Jun. 30, 2018         132,701,579        
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447   $ 822,201          
Balance (Shares) at Dec. 31, 2017 2,000 200   2,833.55          
Balance at Dec. 31, 2017 $ 1,777,781 $ 169,447   $ 822,201 $ 33,623 9,444,831 982,911 (14,030,871) (3,569,506)
Balance (in shares) at Dec. 31, 2017 2,000 200   2,833.55 33,622,829        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock based compensation expense         $ 3,143 671,818     674,961
Stock based compensation expense (in shares)         3,143,501        
Issuance of common stock net of issuance costs of $16,900         $ 32,500 (49,400)     (16,900)
Issuance of common stock net of issuance costs of $16,900 (in shares)         32,500,000        
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.25 and $0.15 per share for December 31, 2017 and $0.10 and $0.001 per share for December 31, 2018       $ (822,201) $ 28,385 800,530     828,915
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.80 and $0.40 per share for December 31, 2016 and $0.25 and $0.15 per share for December 31, 2017 (in shares)       (2,833.55) 28,385,000        
Conversion of Series D Preferred Stock to common stock at $0.25 and $0.10 per share for December 31, 2016 and December 31, 2017, respectively.   $ (169,447)     $ 2,000 167,447     169,447
Conversion of Series D Preferred Stock to common stock at $0.25 per share (in shares)   (200)     2,000,000        
Conversion of Series F Preferred Stock to common stock at $0.10 per share $ (1,777,781)       $ 20,000 $ 1,757,781     $ 1,777,781
Conversion of Series F Preferred Stock to common stock at $0.10 per share (in shares) (2,000)       20,000,000        
Conversion of secured convertible promissory note - related party and accrued interest (in shares)         9,038 1,714,522     1,723,560
Conversion of secured convertible promissory note - related party and accrued interest         $ 9,037,667        
Series B warrant exercises         $ 5,219 $ 1,633,347     $ 1,638,566
Series B warrant exercises (in shares)         5,218,750        
Warrants issued in connection with convertible multi-draw credit agreement, related party             315,080   315,080
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party           90,080     90,080
Net loss for the year               (19,194,236) (19,194,236)
Balance at Dec. 31, 2018         $ 133,908,000 17,528,947 1,297,991 (33,225,107) (15,562,252)
Balance (in shares) at Dec. 31, 2018         133,907,747        
Balance (Shares) at Dec. 31, 2018 0 0   0          
Balance at Mar. 31, 2018         $ 132,414 16,358,271   (22,244,664) (5,753,979)
Balance (in shares) at Mar. 31, 2018         132,414,079        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock based compensation expense           100,603     100,603
Series B warrant exercises         $ 288 77,587     77,875
Series B warrant exercises (in shares)         287,500        
Net loss for the year               (2,662,000) (2,662,000)
Balance at Jun. 30, 2018         $ 132,702 16,528,683   (24,906,664) (8,245,279)
Balance (in shares) at Jun. 30, 2018         132,701,579        
Balance at Dec. 31, 2018         $ 133,908,000 17,528,947 1,297,991 (33,225,107) (15,562,252)
Balance (in shares) at Dec. 31, 2018         133,907,747        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock based compensation expense           171,493     171,493
Warrants issued in connection with convertible multi-draw credit agreement, related party           716,110     716,110
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party           1,584,850     1,584,850
Net loss for the year               (14,774,392) (14,774,392)
Balance at Mar. 31, 2019         $ 133,908 20,001,400   (47,999,499) (27,864,191)
Balance (in shares) at Mar. 31, 2019         133,907,747        
Balance (Shares) at Dec. 31, 2018 0 0   0          
Balance at Dec. 31, 2018         $ 133,908,000 17,528,947 $ 1,297,991 (33,225,107) (15,562,252)
Balance (in shares) at Dec. 31, 2018         133,907,747        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss for the year                 1,130,898
Balance at Jun. 30, 2019         $ 134,095 20,318,672   (32,094,209) (11,641,442)
Balance (in shares) at Jun. 30, 2019         134,095,247        
Balance at Mar. 31, 2019         $ 133,908 20,001,400   (47,999,499) (27,864,191)
Balance (in shares) at Mar. 31, 2019         133,907,747        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock based compensation expense           173,084     173,084
Series B warrant exercises         $ 187 144,188     144,375
Series B warrant exercises (in shares)         187,500        
Net loss for the year               15,905,290 15,905,290
Balance at Jun. 30, 2019         $ 134,095 $ 20,318,672   $ (32,094,209) $ (11,641,442)
Balance (in shares) at Jun. 30, 2019         134,095,247